Pfizer's coronavirus vaccine, Comirnaty, has almost doubled the company's annual revenue, bringing more than $36 billion in 2021 sales alone. AFP
Pfizer's coronavirus vaccine, Comirnaty, has almost doubled the company's annual revenue, bringing more than $36 billion in 2021 sales alone. AFP
Pfizer to invest $470m to expand research on its coronavirus vaccine technology
The drugmaker will construct a building and renovate existing facilities on its campus in Pearl River, New York
